Immunosuppressants improve transplant outcomes but increase complexity of care. Review the steps to develop and implement a nurse-managed immunosuppression program.
Contact hours available until 10/10/18.
Requirements for Successful Completion: Complete the learning activity in its entirety and complete the online CNE evaluation. You will be able to print your CNE certificate at any time after you complete the evaluation.
Faculty, Planners, and Speakers Conflict of Interest Disclosure:
Planning Committee Disclosures: • Denise Murcek – Employee, Fresenius Medical Care • Dawn Koonkongsatian – Employee, Fresenius Medical Care • Melissa Nesmith-Vester – Employee, Aegerion • Elizabeth St. John - Employee, Fresenius Medical Care • Kyra Trappett – Employee, DaVita • Kimberly Waugh – Employee, Fresenius Medical Care
There are no other disclosures to declare.
Commercial Support and Sponsorship: No commercial support or sponsorship declared.
Accreditation Statement: American Nephrology Nurses’ Association is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is a provider approved by the California Board of Registered Nursing, provider number CEP 00910.
Objectives: • Explain how immunosuppressants such as cyclosporine, sirolimus, and tacrolimus have improved transplant outcomes, but increased the complexity of care. • Identify problems associated with medications that require drug level monitoring. • Identify precedents that have facilitated the development of a nurse-managed immunosuppression program. • Describe in general terms how to develop and implement a nurse-managed immunosuppression program.